Neffy a new anaphylaxis treatment device
New needle-free intranasal aerosol adrenaline administration device called Neffy, 2mg, has 30 month shelf life, and FDA and European approval (EUR Neffy). Not yet available in UK, but expected in Summer 2025. Administered via the nose, has absorption enhancer (reduces mucus viscosity). Administer dose of 2mg adrenaline (epinephrine) from 30kg body weight, 1mg device for [...]